Update: 5th extension project to advance oncology candidate with global pharma company

Update: 5th extension project to advance oncology candidate with global pharma company

Physiomics is pleased to announce that it has signed a further extension to a Virtual Tumour project with a major global pharmaceutical company, first announced on 1st March 2012. The extension will cover predicting optimal regimens for a candidate compound and should be completed by the end of 2015.